Engineering Kunitz Domain 1 (KD1) of Human Tissue Factor Pathway Inhibitor-2 to Selectively Inhibit Fibrinolysis: PROPERTIES OF KD1-L17R VARIANT

Tissue factor pathway inhibitor-2 (TFPI-2) inhibits factor XIa, plasma kallikrein, and factor VIIa/tissue factor; accordingly, it has been proposed for use as an anticoagulant. Full-length TFPI-2 or its isolated first Kunitz domain (KD1) also inhibits plasmin; therefore, it has been proposed for use...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Bajaj, Madhu S., Ogueli, Godwin I., Kumar, Yogesh, Vadivel, Kanagasabai, Lawson, Gregory, Shanker, Sreejesh, Schmidt, Amy E., Bajaj, S. Paul
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Biochemistry and Molecular Biology 2011
Θέματα:
Protein Structure and Folding
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3039392/
https://ncbi.nlm.nih.gov/pubmed/21115497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M110.191163
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια